• 1
    National Cancer Institute. Clinical Alert. Bethesda, MD: Department of Health and Human Services, 1988.
  • 2
    Fisher B, Redmond C, Dimitrov NV et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 1989; 320: 473478.
  • 3
    Fisher B, Constantino J, Redmond C et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989; 320: 479484.
  • 4
    Mansour EG, Gray R, Shatila AH et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: An intergroup study. N Engl J Med 1989; 320: 485490.
  • 5
    The Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 1989; 320: 491496.
  • 6
    Glick JH. Meeting highlights: Adjuvant therapy for breast cancer (commentary). J Natl Cancer Inst 1988; 80: 471475.
  • 7
    McGuire WL, Abeloff MD, Fisher B et al. Adjuvant therapy in node-negative breast cancer. Breast Cancer Res Treat 1989; 13: 97115.
  • 8
    Rosner D, Lane WW, Nemoto T. Predicting disease-free survival in node-negative breast cancer patients: Do they need adjuvant therapy (Abstr #1008)? Proc Am Assoc Cancer Res 1989; 30: 253.
  • 9
    Rosner D, Lane WW. Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy. Cancer 1990; 66: 199205.
  • 10
    Kinne DW, Petrek JA, Osborne MP et al. Breast cancer in situ. Arch Surg 1989; 124: 3336.
  • 11
    Schuh ME, Nemoto T, Penetrante RB et al. Intraductal carcinoma: Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986; 121: 13031307.
  • 12
    Von Reuden DG, Wilson RE. Intraductal carcinoma of the breast. Surg Gynecol Obstet 1984; 158: 105111.
  • 13
    Rosner D, Nemoto T, Dao T. Detection of asymptomatic breast cancer in the second breast by mammographic follow-up: A 5-year survey. In: NieburgsHE, ed. Prevention and Detection of Cancer. New York: M. Dekker, 1978; 12811285.
  • 14
    Rosner D, Bedwani RN, Vana J et al. Noninvasive breast carcinoma: Results of a national survey by the American College of Surgeons. Ann Surg 1980; 192: 139147.
  • 15
    Swain SM. Ductal carcinoma in situ: Incidence, presentation, guidelines to treatment. Oncology 1989; 3: 2542.
  • 16
    Gallagher WJ, Koerner FC, Wood WC. Treatment of intraductal carcinoma with limited surgery: Long-term follow-up. J Clin Oncol 1989; 7: 376380.
  • 17
    Ketcham AS, Moffat FL. Vexed surgeons, perplexed patients and breast cancer which may not be cancer. Cancer 1990; 65: 3887393.
  • 18
    Schwartz GP, Patchefsky AS, Finkelstein SD et al. Nonpalpable in situ ductal carcinoma of the breast: Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg 1989; 124: 2932.
  • 19
    Durkin K, Haagensen CD. An improved technique for the study of lymph nodes in surgical specimens. Ann Surg 1980; 191: 419429.
  • 20
    Pathology Working Group, Breast Cancer Task Force. Standardized management of breast cancer specimens. Am J Clin Pathol 1973; 60: 789798.
  • 21
    Centralized Cancer Patient Data System (CCPDS). Survival rates for US comprehensive cancer center patients, admissions 1977–1982. Statistical analysis and quality control center. Seattle, WA: Fred Hutchinson Cancer Research Center, 1985; 3: 13.
  • 22
    Taber L, Gad A, Holmberg LH et al. Reduction in mortality from breast cancer after mass screening with mammography: Randomized trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829832.
  • 23
    Thomas BA, Price JL. The Guilford breast screening project: A 6-year assessment. Recent Results Cancer Res 1987; 105: 6772.
  • 24
    Patchefski AS, Schwartz GF, Finkelstein SD et al. Heterogeneity of intraductal carcinomas of the breast. Cancer 1989; 63: 731741.
  • 25
    Anderson TJ, Alexander F, Chetty U et al. Comparative pathology of prevalent and incident cancers detected by breast screening. Lancet 1986; 1: 519523.
  • 26
    Lagios MD, Margolin FR, Westdahl PR et al. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618624.
  • 27
    Gump FE, Jicha DL, Ozello L. Ductal carcinoma in situ (DCIS): A revised concept. Surgery 1987; 102: 790795.
  • 28
    Fisher ER, Sass R, Fisher B et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): Intraductal carcinoma (DCIS). Cancer 1986; 56: 197208.
  • 29
    Recht A, Danoff B, Solin LJ et al. Intraductal carcinoma of the breast: Results off treatment with excisional biopsy and irradiation. J Clin Oncol 1985; 3: 13391343.
  • 30
    Zefrani B, Fourquet A, Vilcoq JR et al. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer 1987; 59: 675681.
  • 31
    Schnitt SJ, Connolly JL, Khethy U et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 1987; 59: 675681.
  • 32
    Holland R, Connolly JL, Gelman R et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8: 113118.
  • 33
    Kurtz JM, Jacquemier J, Amalric R et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservative surgery. Cancer 1990: 65: 18671878.
  • 34
    Schnitt SJ, Silen W, Sadowski NL et al. Current Concepts: Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988; 318: 898903.
  • 35
    Howard PW, Locker AP, Dowle CS et al. In situ carcinoma of the breast. Eur J Surg Oncol 1989; 15: 328332.
  • 36
    Rosner D, Joshua H, Gutglas H. La valeur de la ponction biopique et de l'examen cytologique dans la radiotherapie preoperatoire du cancer du sein. J Radiol 1964; 11: 691696.
  • 37
    Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990; 125: 12981302.